William Jl Rieflin, Director at RAPT Therapeutics, Inc. (RAPT), bought 10,000 shares at $16.22 ($162K) on 2020-11-19, disclosed to the SEC on 2020-11-20.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| XNPT | BUY | 2011-12-16 | $39K | — | Filing → |
| XNPT | BUY | 2011-11-22 | $44K | — | Filing → |
| XNPT | BUY | 2011-11-09 | $27K | — | Filing → |